Ao minuto: Irão rejeita acordo de cessar-fogo. Trump considera proposta "significativa mas insuficiente"

[GAB]

site:
http://www.radialenergyinc.com

[GAB]

GAB,

Já viu a ACHI? Subiu bem nestes dias, a queda de hoje foi com pouco volume e conseguiu fechar acima da MM50, pareçe-me com força para voltar a tentar a área dos 0,80$.

Cumprimentos,
D.

AmeriChip International Inc. (ACHI.OB)
Tinha ordem ordem de compra, 4,5% cart( unica liquidez que tenho) a $0,05, foi lá mas a minha O.C. não foi satisfeita.

[Dracull]

GAB,

Já viu a ACHI? Subiu bem nestes dias, a queda de hoje foi com pouco volume e conseguiu fechar acima da MM50, pareçe-me com força para voltar a tentar a área dos 0,80$.

Cumprimentos,
D.

[Dracull]

a X-Change está com uma pujança, sim senhor, tentei entrar hoje mas nao consegui, vou esperar por um retracement.

[GAB]

Senticore Inc. (SNIO.OB)

Site:
http://www.senticore.com/

NEWS-DIVIDEND:
Wednesday June 28, 7:00 am ET
SAN ANTONIO, June 28 /PRNewswire-FirstCall/ -- Senticore, Inc. (OTC Bulletin Board: SNIO - News) has declared its first dividend in the history of the company. The cash dividend will be distributed to all shareholders of record on close of business on June 30, 2006. The amount and timing of the dividend will be based on funds derived from sale of its 882,353 shares in AdZone Research, Inc., which the company received December 29, 2004 from a joint venture transaction with AdZone. The acquisition and intent to dividend the shares was announced in the company's Security and Exchange Commission's filings of Forms 10-KSB for 2004 and 2005 and was contingent upon AdZone's registration of the shares or the application of Rule 144.

[GAB]

X-Change Corp. (XCHC.OB)

site:
http://www.x-changecorp.com/

The X-Change Corporation engages in the acquisition, exploration, and development of oil and gas properties in Texas. The company owns 55 wells in 5 counties in east Texas, including Rusk, Gregg, Smith, Upshur, and Cherokee.Its other wholly owned subsidiary, AirGATE Technologies, Inc., develops and acquires radio frequency identification, wireless technology, and intelligent sensor network technologies. The company was incorporated in 1969 as Diversified Technologies Group, Inc. and changed its name to The X-Change Corporation in 2001. The X-Change Corporation is based in Allen, Texas.

[GAB]

Biogenerics Ltd. (BIGN.PK)
site:
http://www.bignltd.com/pressreleases.html

[GAB]

Lincoln Electric Holdings Inc. (LECO)

site:
http://www.lincolnelectric.com./

Lincoln Electric Holdings, Inc., through its subsidiaries, engages in the manufacture and resale of welding and cutting products worldwide. Its welding products include arc welding power sources, wire feeding systems, robotic welding packages, fume extraction equipment, consumable electrodes, and fluxes, as well as regulators and torches used in oxy-fuel welding and cutting. The company’s customers comprise companies operating in general metal fabrication; infrastructure, including oil and gas pipelines and platforms, buildings, bridges, and power generation; transportation and defense industries; equipment manufacture in construction, farming, and mining; retail resale; and rental market. Lincoln Electric Holdings sells its products principally through industrial distributors, retailers, as well as directly to users of welding products in North America; and through direct sales force internationally. The company was founded in 1895 and is headquartered in Cleveland, Ohio.

NEWS/Infos:
- First Quarter sales increase 29% to a record $468.4 million
- Diluted Earnings Per Share (EPS) of 86 cents vs. 53 cents, up 62%

- Net income increases 65% to $36.7 million

link: http://news.moneycentral.msn.com/ticker ... ol=US:LECO

[GAB]

NOVO Ticker e passa a pertencer ao AMEX:
XETHANOL CORPORATION (XNL)


INFO:
http://www.xethanol.com/

Xethanol Common Stock To Trade on AMEX June 20

NEW YORK--(BUSINESS WIRE)--June 19, 2006--Xethanol Corporation (OTCBB: XTHN) announced today that its common stock will commence trading on The American Stock Exchange(R) (AMEX(R)) on Tuesday, June 20 under the ticker symbol XNL. The company's specialist will be AIM Securities Corporation.

About Xethanol Corporation

Xethanol Corporation's goal is to be the leader in the emerging biomass-to-ethanol industry. Xethanol's mission is to optimize the use of biomass in the renewable energy field and convert biomass that is currently being abandoned or land filled into ethanol and other valuable co-products. Xethanol's strategy is to deploy proprietary biotechnologies that will extract and ferment the sugars trapped in these biomass waste concentrations. Xethanol's strategic value proposition is to produce ethanol and valuable co-products cost effectively with ethanol plants located closer to biomass sources. In Iowa, Xethanol owns two ethanol production facilities, where it is deploying these technologies. For more information about Xethanol, please visit its website at http://www.xethanol.com. To receive information on Xethanol in the future, please click on the following link: http://www.xethanol.com/alerts.htm?b=1387&l=1

[GAB]

Primedex Health Systems Inc. (PMDX.OB)

Primedex Health Systems, Inc. operates outpatient diagnostic imaging facilities in California. It offers various combinations of magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, X-ray, and fluoroscopy. As of October 31, 2005, it operated a group of regional networks comprised of 57 fixed-site, freestanding outpatient diagnostic imaging facilities in California. Primedex Health Systems, Inc. was incorporated in 1985 and is headquartered in Los Angeles, California.

http://www.radnetonline.com


NEWS:
Primedex Health Systems Reports Record Second Quarter 2006 Results
Wednesday June 14, 7:07 pm ET

LOS ANGELES--(BUSINESS WIRE)--June 14, 2006--Primedex Health Systems, Inc. (OTCBB:PMDX - News):
For the first six months of its fiscal 2006, revenue increases 12.7% and EBITDA increases 16.2%
Company reaches operational profitability in second quarter, after one-time adjustment related to its recent financing
Company reports second quarter revenue and EBITDA of $39.6 million and $8.8 million, respectively.
Fonte:
http://biz.yahoo.com/bw/060614/20060614006028.html?.v=1

OUTRA DO MESMO RAMO/SECTOR:
HEALTHSOUTH Corp. (HLSH.PK)

[GAB]

I2 Telecom International, Inc. (ITUI.OB)

i2 Telecom International, Inc. provides telecommunications services employing voice over Internet protocol (VoIP) technology. Its products include VoiceStick that allows the user to make domestic and international long distance calls via the Internet, with the use of an included handset; and InternetTalker integrated access device, which enables the user to make worldwide phone calls over the Internet. The company also offers microgateway adapters, integrated access devices, and VoIP long distance and other communication services to subscribers. i2 Telecom was founded in 2002 and is headquartered in Atlanta, Georgia.

http://www.i2telecom.com/
http://www.i2telecom.com/Products.aspx
http://www.voicestick.com


News/infos:
[June 12, 2006]
i2Telecom Announces record breaking Web Site Volume for its VoiceStick(TM) VoIP Service - www.voicestick.com; 250% increase in unique visitors and more than double the Sign-ups for Voicestick(TM) in May 2006.
http://ipcommunications.tmcnet.com/news ... 169920.htm

[GAB]

Notas sobre a EDNE:

[GAB]

Listed: USA, OTC.BB: EDNE

[GAB]

IBSG International Inc. (IGII.OB)
Intelligent Business Systems Group International

IBSG International, Inc. is a holding company for two software subsidiaries: Intelligent Business Systems Group, Inc. (IBSG), a provider of turnkey digital service center software; and Secure Blue, Inc., a Sarbanes-Oxley and security software developer.

http://www.ibsgi.com/

[GAB]

EOP BIODIESEL
http://www.eopbiodieselag.de/start.html

[GAB]

Não é OTCBB mas interessa-me para eventual futuro trade:


Acusphere Inc. (ACUS)
http://www.acusphere.com
Corporate Overview:

Acusphere, Inc.™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microsphere technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. Our three initial product candidates are designed to address large unmet clinical needs within cardiology, oncology and asthma. Our lead product candidate is a cardiovascular drug in Phase 3 clinical development for the detection of coronary heart disease, the leading cause of death in the United States.

We created our three initial product candidates using technology that enables us to control the size and porosity of microspheres in a versatile manner, so we can customize the microspheres to address the delivery needs of a variety of drugs. We are focused on creating porous microspheres that are smaller than red blood cells. Small microspheres are important for delivering drugs intravenously so that they can pass through the body's smallest blood vessels, for increasing the surface area of a drug so that the drug will dissolve more rapidly, and for delivering drugs to the lung via inhalation. Porosity is important for entrapping gases in microspheres, for controlling the release rate of the drug from a microsphere, and for targeting inhaled drugs to specific regions of the lung.

We have initially applied this technology in our research and development efforts in the following areas:

AI-700, Intravenous Delivery of Gas for Ultrasound Contrast. We specifically designed AI-700 to assess myocardial perfusion, or blood flow in the heart muscle, a sensitive marker for coronary heart disease. AI-700 is a cardiovascular drug that enables stress echocardiography, or ultrasound of the heart, to obtain information on myocardial perfusion. The current standard for assessing myocardial perfusion is a nuclear stress test. Stress echocardiography is relatively inexpensive, more broadly available, fast and radiation-free, but without a perfusion contrast agent is incapable of assessing myocardial perfusion directly and can only detect wall motion abnormalities, which are downstream consequences of inadequate perfusion. Currently, there is no ultrasound contrast agent for myocardial perfusion assessment approved by the U.S. Food and Drug Administration (FDA). We believe the cardiac indication for an ultrasound contrast agent capable of myocardial perfusion assessment could address a $2.4 billion potential market in the United States. AI-700 is an ultrasound contrast agent that is comprised of porous microspheres containing gas, an effective reflector of ultrasound. AI-700 acts as a tracer of abnormal blood flow, which is associated with many life-threatening diseases, such as coronary heart disease. Future indications may exist for other diseases associated with abnormal blood flow, such as various forms of cancer, renal artery stenosis and deep vein thrombosis. AI-700 clinical studies are designed to evaluate the ability to detect coronary heart disease using echocardiography with our drug compared to nuclear stress testing. Based on our Phase 2 studies, we believe stress echo with AI-700 has the potential to obtain information comparable to the nuclear stress test. We also believe stress echo with AI-700 can provide cost and convenience advantages. We have completed the first of two AI-700 Phase 3 pivotal trials, the RAMP-1 trial (Real-time Myocardial Perfusion with echocardiography), and completed enrollment in the second trial, RAMP-2 in June 2006. As of that date, over 1000 patients had been enrolled in the AI-700 clinical program including 321 patients in RAMP-1 and approximately 450 patients in RAMP-2.
AI-850, First Clinical-Stage Product Candidate from our Hydrophobic Drug Delivery System, HDDS™. Hydrophobic drugs are drugs that do not dissolve well in water and are often difficult to formulate, especially for intravenous delivery. We have demonstrated that our HDDS improves the dissolution rate of a variety of hydrophobic drugs. Our first clinical application of HDDS is AI-850, which has completed Phase I clinical trials. AI-850 is an improved formulation of paclitaxel, the active ingredient in Taxol, a leading cancer drug that generated revenues of $747 million in 2004. To dissolve paclitaxel, Taxol contains Cremophor, which is believed to cause severe hypersensitivity reactions. We have increased the dissolution rate of paclitaxel by converting it into small sponge-like microspheres thereby increasing the surface available for interaction with water. AI-850 is a Cremophor-free, readily dissolvable formulation of paclitaxel that can be delivered intravenously. We completed a Phase I clinical trial of AI-850 in which we demonstrated the potential to deliver higher doses of paclitaxel to treat patients with extensive prior taxane therapy than is customarily delivered with Taxol to treat taxane naïve patients with metastatic breast cancer. In addition to paclitaxel, we have demonstrated that our HDDS technology improves the dissolution rate of a variety of hydrophobic drugs, including COX-2 inhibitors, taxanes, calcium channel blockers and anti-fungals.
AI-128, First Clinical-Stage Product Candidate from Our Pulmonary Drug Delivery System, PDDS™. Many inhaled respiratory drugs are immediate release formulations that must be inhaled multiple times per day and deliver peak and trough drug levels that can cause increased toxicity or inadequate efficacy. AI-128 is a sustained release formulation of an FDA-approved, immediate release asthma drug. AI-128 is comprised of slowly dissolving microspheres with an appropriate size and porosity to enable them to be targeted to the upper lung, where the asthma drug can be released with reduced systemic exposure. The FDA-approved formulation must be inhaled multiple times per day, which discourages patient compliance. Non-compliance can lead to complications that result in increased emergency room visits and hospitalization. We believe AI-128 may allow patients to take treatments less frequently and may offer improved safety through minimization of peak and trough drug levels associated with the FDA-approved formulation of the drug. We completed a European Phase I clinical trial for AI-128 that demonstrated targeted delivery to the upper lung and sustained release of the drug for up to 24 hours. Many inhaled respiratory drugs are immediate release formulations that could potentially benefit from our PDDS technology.

[GAB]

VITASTI INC (VITS.OB)
http://www.vitasti.com/index.html
http://www.welwind.com/

Alternative Energy& Health & Wellness.

[GAB]

ERHC Energy Inc. (ERHE.OB)
http://www.erhc.com/index.html

Company History :

ERHC Energy (OTCBB:ERHE) was formed in 1986, as a Colorado corporation.


In 1996, ERHC Energy began its current operations as an independent oil and gas company.


In April 2003, ERHC Energy entered into an administration agreement with the Joint Development Authority (JDA), fully implementing the company’s preferential rights to interests in its Joint Development Zone (JDZ) acreage between the Democratic Republic of São Tomé & Principe and the Federal Republic of Nigeria.


In August 2004, ERHC Energy entered into a participation agreement with Pioneer Natural Resources to jointly apply for rights in the production sharing contract for block 2 of the JDZ, and in December 2004 for similar rights for block 3.


In September 2004, ERHC Energy entered into a participation agreement with Noble Energy International, Ltd., a subsidiary of Noble Energy, Inc., to jointly apply for rights in the production sharing contract for block 4 of the JDZ.


In December 2004, ERHC Energy submitted bids as a consortium for Blocks 2, 3, and 4. The company had previously exercised its option rights in all five Blocks on offer in the 2004 JDZ Licensing Round.


Effective December 31, 2004, ERHC Energy terminated its management services agreement with Chrome Oil Services.


As of January 1, 2005, ERHC Energy assumed direct responsibility for costs and expenses of its officers and staff, and the lease obligation of its office space.


In February 2005, Environmental Remediation Holding Corporation (ERHC) changed its name to ERHC Energy Inc., by decision of its shareholders.


In May 2005, the Nigeria-São Tomé and Príncipe JDA awarded five blocks on offer in the 2004 Licensing Round, with the following results:


Block 2 — the ERHC/Devon/Pioneer consortium was awarded 65% interest, inclusive of ERHC Energy's 30% signature bonus free interest. The consortium was designated operator for Block 2.


Block 3 — the ERHC/Devon/Pioneer consortium was awarded 25% interest, inclusive of ERHC Energy's 20% signature bonus free interest.


Block 4 — the ERHC/Noble consortium was awarded 60% interest, inclusive of ERHC Energy's 25% signature bonus free interest. The consortium was designated operator for Block 4.


In making the awards for Blocks 5 and 6, the JDA confirmed ERHC Energy's 15 percent interest in each Block.


ERHC Energy's interest in Block 6 is free of signature bonus


In June 2005, ERHC Energy consortium partner Devon Energy announced its decision to decline the bid award due to low interest the company would receive as one of three consortium partners. ERHC Energy and Pioneer Natural Resources Co. agreed to proceed as consortium partners in Blocks 2 and 3 with Pioneer designated operator for Block 2.


Proceedings for the ERHC/Pioneer and ERHC/Noble consortiums will include negotiation of Joint Operation Agreements and Production Sharing Contracts, which the JDA expects to be completed within 90 days of the awards being announced.


ERHC Energy’s current focus is to exploit its assets in the Joint Development Zone (JDZ) and to evaluate other opportunities in West Africa.

[GAB]

Open Energy Corp. (OEGY.OB)

http://www.openenergycorp.com/en/products/index.asp

Dear Open Energy Shareholders, Stakeholders, Potential Investors, and Clients

I am proud to report that we have successfully completed the transformation of Barnabus Energy into Open Energy Corporation. In less than a year, we have sold our oil and gas holdings, acquired Solar Roofing Systems and Connect Renewable Energy together with their SolarSave™ product lines, licensed and built the first SunCone™ CSPsystem, secured funding, strengthened our management team and assembled a distinguished board of independent directors.

Our new identity reflects the mission and vision of the Company. The logo is based on the architecture of a photovoltaic cell. It incorporates the sun (the source of all energy on earth) and a leaf (nature’s own solar cell). Blue for water, green for life: In whole, a representation of an organization open to the bright future of renewable energy. Our goal is to harness the power of the sun to meet the growing resource demands of sustainable 21st Century development.

By developing renewable energy alternatives, we will reduce green house gas emissions, preserve natural resources, lessen our dependence upon foreign oil, and help ensure a healthy and positive future for our children and their children. We honor your trust and thank you for your support in the formation and ongoing success of Open Energy Corporation.

Sincerely,

David Saltman, President & CEO
Open Energy Corporation

[GAB]

Liberty Star Gold Corp. (LBTS.OB)

http://www.libertystargold.com/index.asp

Liberty Star Gold Corp., through its wholly owned subsidiary, Big Chunk Corp., engages in the acquisition and exploration of mineral properties in the state of Alaska. It holds interest in Big Chunk project, which includes 1,718 mineral claims covering approximately 421 square miles in the Iliamna region of southwestern Alaska, located on the north side of the Cook Inlet, approximately 265 miles southwest of the city of Anchorage, Alaska; Bonanza Hills project, including 163 mineral claims covering approximately 40.75 square miles in southwestern Alaska approximately 40 miles northeast of the northern boundary of the Big Chunk claims; and North Pipes project, which comprises 651 Federal mining claims covering approximately 21 square miles on the Colorado Plateau Province of Northern Arizona. The company was founded in 2001. It was formerly known as Titanium Intelligence, Inc. and changed its name to Liberty Star Gold Corp. in 2004. The company is based in Tucson, Arizona.

[GAB]

Green Energy Resources (GRGR.PK)
http://www.greenenergyresources.com/renewable.html


Green Energy Resources (formally New York International Log & Lumber Co.) is a green bio-energy supply company, dedicated to preserving world forests, not cutting them.

Green Energy Resources is a publicly traded, environmentally friendly "GREEN STOCK", (symbol GRGR) working with industry for "green certificates", a 21st century currency.

Green Energy Resources is dedicated to working with power generating utilities, government, and corporations for carbon emission strategies, and is the only American company selected to supply the Euro Energy Group.




INFO/News:
NEW YORK, NEW YORK--(MARKET WIRE)--Jun 6, 2006 -- Green Energy Resources (Other OTC:GRGR.PK - News ) has selected Mr.Joseph Mcgowan as CFO. Mr. Mcgowan is a CPA with over 25 years experience at the institutional level.Mcgowans expertise includes management of financial audits, internal control audits and Initial Public Offerings ( IPO's).His outstanding skills will benefit the company in preparing financial statements,regulatory reports and SEC Filings. Joseph Mcgowan said".Green Energy Resources has an outstanding business model, and is second to none in industry leadership,and vision. It is my objective to bring them into conformity with financial markets."Green Energy Resources plans to list on the London Aim Market and the Nasdaq Bulletin Board. The company has no debt and produced profits in 2004 and 2005. Mr.Mcgowan will be based in New York.
In other company news, Green Energy Resources has completed requirements for the Nasdaq OTC to trade( bid and ask) on its new tiered system.Green Energy Resources SEC attorney Jack Halperin, has been working with Pink sheets to insure the requirements have been met. New CFO Mcgowan will take an active role in the near future in conjunction with Mr. Halperin.

CEO, Joseph Murray has focused his primary attention on new contract opportunities. The London Aim market has slowed appreciably in 2006 with a backlog of listings, particulary of US companies. The Aim market has effectively delayed newcomers 6 or more months. Mr.Murray will announce plans to go to China this summer in an upcoming news bulletin. Mr. Murray's plans are to return to Europe within a few weeks for additional contract talks for deliveries in 2006.

[GAB]

High oil prices drive search for alternative fuels: BSLM.OB
As pain at the pump increases, research into new energy sources, from wind to biomass, draws more of the spotlight

By Dave Carpenter

ASSOCIATED PRESS

CHICAGO - The future of energy is bright in Said Hallaj's invention lab at the Illinois Institute of Technology, and not just because of the solar window that lies in development on a table. All around the lab are advanced alternative energy projects that testify to the war on oil that's proceeding quietly at laboratories and research centers across the country. "The implications if we succeed are unbelievable," "You're coming up with a solution that is clean and advanced -- (good for) energy, the environment and people who are burdened by high prices. "Solutions for high gasoline prices might seem painfully far off to drivers as summer travel season begins, but experts say the skyrocketing costs of oil and gas have given new momentum to the push to develop alternative fuels and alternative energy sources.

The efforts are readily apparent in the nation's heartland, where a boom in ethanol is expanding and scientists at laboratories far and wide are working to turn agricultural waste or "biomass" such as switchgrass, wheat straw, cornstalks and miscanthus into a fuel called cellulosic ethanol that could be produced commercially to reduce U.S. dependence on oil.

[GAB]

Earth Search Sciences Inc. (ESSE.OB)
(Nonmetallic Mineral Mining)
http://www.earthsearch.com/index.php?sc=11
Earth Search Sciences Inc. provides airborne hyperspectral remote sensing services for a wide range of uses from exploration and monitoring of valuable natural resources to homeland security. With the resurgence of the mining industry and the emphasis for new sources of supply for oil & gas, there is greater demand in using exploration tools that are faster and more accurate. Hyperspectral technology is just that.


NEWS:
Title: EARTH SEARCH SCIENCES INC. COMPLETES UNRESTRICTED LICENSE FOR PATENTED TECHNOLOGY TO RECOVER OIL & GAS FROM RICH COLORADO OIL SHALE WITH STRONG ALLIANCE
Date: May 30th, 2006

[Dracull]

Eis um excelente exemplo de uma empresa capaz de ser ao mesmo tempo, uma empresa "green", de tinha falado noutro post, e uma empresa capaz de criar combustivel.

Pareçe ter muito € para dar.

Cumprimentos,
D.

[GAB]

Bio-Solutions Manufacturing Inc. (BSLM.OB)

http://www.biosolutionsmfg.com/

HATTIESBURG, MS--(MARKET WIRE)--Jun 5, 2006 -- Bio Solutions Manufacturing, Inc. (OTC BB:BSLM.OB - News ) (Frankfurt:B2T.F - News ) announced today that it has entered into a definitive agreement to acquire BioExtraction Services, Inc., the owner of the proprietary BioExtractor system, in a stock-for-stock transaction, expanding Bio Solutions' ability to manufacture biodiesel from waste, oil, and grease. The transaction has been approved by Bio Solutions' Board of Directors and is subject to standard closing conditions, including any required regulatory and third-party approvals. Bio Solutions expects to complete the transaction on or before June 30, 2006.
David Bennett, President of Bio Solutions, said, "This acquisition plays a crucial role in our strategic plans to become a major manufacturer of biodiesel from waste, oil, and grease."

BioExtraction, within its franchise network, will collect the fats, oil, and grease extracted from its commercial cooking establishment customers, using the new technology of the BioExtractor. Bio Solutions believes that the BioExtraction's proprietary technology will allow it to produce biodiesel using extraction technology at an approximate cost of $0.80 per gallon, whereas Bio Solutions estimates that the cost of producing biodiesel using a competing technology is approximately $2.00 per gallon.

Peter Chapin, the inventor of the BioExtractor, will serve as Chief Executive Officer and President of BioExtraction.

The BioExtractor is made of three compartments through which waste travels before reaching grease traps of commercial cooking establishments. The first compartment allows the grease to flow over the top into the second compartment while trapping sediment in a removable, cleanable tray. The second compartment, using patent pending technology, removes 99.9% of the FOGs that flow through the extractor. The third compartment gives opportunity for the introduction of microbial products to remediate any remaining FOGs that enter the grease trap, and later, the municipal collection system.

About Bio-Solutions Manufacturing, Inc.:

Bio-Solutions Manufacturing has developed microbiological products for waste bioremediation. The company currently services many municipal collection systems and a growing number of food service facilities in the United States. The company's products have been approved by an ever-growing number of municipalities for use in food service facilities that produce waste products introduced into the municipal collection systems. Bio-Solutions' products treat waste in an environmentally friendly and safe manner in compliance with Federal and State government standards.

Bio-Solutions has developed a line of environmentally friendly cleaning products that include all purpose cleaner, carpet cleaner, concrete and asphalt cleaner, and floor soap. With this line of products, it is enabling Bio-Solutions to broaden its customer base to the residential areas as well as the businesses and municipalities.

Safe Harbor for Forward-Looking Statements:

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve risks and uncertainties and are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in the future periods to differ materially from forecasted results.



Contact:
For More Information, Please Contact:
Patricia Spreitzer
702-222-4781



--------------------------------------------------------------------------------
Source: Bio-Solutions Manufacturing, Inc.

BIO-SOLUTIONS MANUFACTURING, INC.








Price:$.50

52 Week Range: $0.19 - $1.05

Market Cap: $8.06 M +/-

Shares Outstanding: 18.31 M

Symbol :OTCBB: BSLM


Bio-Solutions Manufacturing, Inc . (BSLM) is a technology provider of biological solutions to meet the demand of industries seeking environmentally friendly forms of waste bioremediation. Bioremediation is the treatment of pollutants or waste (e.g. grease or manure) by the use of microorganisms that break down the undesirable substances into harmless, elemental forms such as carbon dioxide and water.


Bio-Solutions have developed superior microbiological products for waste bioremediation. Bio-Solutions currently service many municipal collection systems and a growing number of food service facilities in the United States. The company's products have been approved by an ever-growing number of municipalities for use in food service facilities that produce waste products introduced into the municipal collection systems. Bio-Solutions' products treat waste in an environmentally friendly and safe manner in compliance with Federal and State government standards.



By expanding to 11 new franchise companies, having territories with at least 1450 commercial cooking establishments each, BSLM has a vast market potential. With the invention of the Actceptor, the first unique automatic insulated solids, oil, and water extractor of its kind, BSLM is broadening its customer bases to residential, business, and municipality areas. In the new areas, the company will expect strong revenues in the near future, due to new product lines.

With competing companies such as, Shaw Group Inc. and US Microbics having market caps of $2.36B and $4.67M respectively, there is a strong market potential for a company like Bio-Solutions Manufacturing Inc, trading at its current levels.